Why is Welcure Drugs falling/rising?
As of 06-Oct, Welcure Drugs & Pharmaceuticals Ltd is currently priced at 6.33, reflecting a recent increase but a significant decline of 35.47% over the past month. Despite outperforming its sector in the short term, the stock's long-term trends indicate underperformance and declining investor participation.
As of 06-Oct, Welcure Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 6.33, which reflects a rise of 0.3 or 4.98%. The stock has shown a strong performance today, outperforming its sector by 4.87% and has gained consecutively for the last three days, resulting in a total return of 15.09% during this period. However, it is important to note that while the stock has risen recently, it has a significant decline of 35.47% over the past month and a year-to-date drop of 45.76%. Additionally, the stock's delivery volume has decreased by 23.14% compared to the five-day average, indicating a potential decline in investor participation, which could impact future price movements.Broader Market Context: In comparison to the benchmark Sensex, which has increased by 1.77% over the past week, Welcure Drugs has outperformed with a return of 9.90%. This short-term performance contrasts sharply with its longer-term trends, where the stock has underperformed significantly over the past month and year-to-date, while the Sensex has shown a modest gain. The stock's recent upward movement may be attributed to short-term trading dynamics rather than a fundamental recovery, as indicated by its lower moving averages and declining investor participation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
